In the news release, Novocure(TM) to Present NovoTTF(TM) Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology, issued 29-May-2012 by Novocure

PORTSMOUTH, N.H., May 29, 2012 /PRNewswire/ -- Novocure(TM), a commercial stage private oncology company, announced today that data from pre-clinical and clinical studies evaluating NovoTTF(TM)

PORTSMOUTH, N.H., May 24, 2012 /PRNewswire/ -- Novocure(TM), a commercial stage private oncology company, announced that by June 1, eight additional clinical centers of excellence will join

PORTSMOUTH, N.H., May 21, 2012 /PRNewswire/ -- Results of the first randomized controlled trial to compare a novel cancer treatment modality delivering

PORTSMOUTH, N.H., May 14, 2012 /PRNewswire/ -- In its ongoing effort to help patients, their caregivers and health care professionals easily find detailed information about its